𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Erratum to: TheTGFBR1*6A/9A polymorphism is not associated with differential risk of breast cancer

✍ Scribed by Gabrielle Colleran; Niall McInerney; Andrew Rowan; Ella Barclay; Angela M. Jones; Catherine Curran; Nicola Miller; Michael Kerin; Ian Tomlinson; Elinor Sawyer

Publisher
Springer US
Year
2011
Tongue
English
Weight
108 KB
Volume
131
Category
Article
ISSN
0167-6806

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

CDH1 c-160a promotor polymorphism is not
CDH1 c-160a promotor polymorphism is not associated with risk of stomach cancer
✍ Paul D.P. Pharoah; Carla Oliveira; JosΓ© Carlos Machado; Gisella Keller; Holger V πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 French βš– 66 KB

We have combined data from case control studies designed to test the hypothesis that the c-160a promotor polymorphism in the gene coding for the cell adhesion molecule E-cadherin (CDH1) is associated with stomach cancer. A total of 899 individuals (433 patients and 466 controls) were analyzed. The g

Identification of a DMBT1 polymorphism a
Identification of a DMBT1 polymorphism associated with increased breast cancer risk and decreased promoter activity
✍ Sandrine Tchatchou; Angela Riedel; Stefan Lyer; Julia Schmutzhard; Olga Strobel- πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 192 KB πŸ‘ 1 views

According to present estimations, the unfavorable combination of alleles with low penetrance but high prevalence in the population might account for the major part of hereditary breast cancer risk. Deleted in Malignant Brain Tumors 1 (DMBT1) has been proposed as a tumor suppressor for breast cancer